/
/
/

Natco Pharma Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)828.65
Volume (₹)6,250.00
High (₹)994.35
Upper Circuit994.35
Low (₹)787.20
Lower Circuit662.95
Prev Close838.30
52W High (₹)1,226.80
Price787.20
52W Low (₹)787.20

Share Market Cap & Key Ratios Overview

M.Cap (₹)15010.30 Cr
Div. Yield (%)0.60
PE Ratio13.12
Debt to Equity0.04
Price to Book1.88
Book Value424.97
EPS (TTM)63.89
Face Value2.00
ROE (%)27.98

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
NATCOPHARMNSE
LTP
1W Low
1W High
Market cap (₹)
1963+34 (1.76%)
1881.80
2183.80
4,56,833Cr
9555+390 (4.26%)
8750
10010
2,45,426Cr
4857-108.5 (-2.19%)
4711.50
5252.50
1,87,320Cr
1119.9-47.9 (-4.10%)
1086.40
1230
1,13,217Cr
1499+76 (5.34%)
1300
1523.50
1,12,212Cr
1784.8-76.8 (-4.13%)
1697.20
2024
1,01,155Cr
2321+168 (7.80%)
2004.50
2321
97,626Cr
2560.6+204.1 (8.66%)
2317
2560.60
96,859Cr
1279.8+108.8 (9.29%)
1151
1279.80
96,406Cr
1653.1-30.2 (-1.79%)
1603.50
1818.40
93,614Cr
787.2-62 (-7.30%)
787.20
994.35
15,010Cr

Key Highlights of Natco Pharma Ltd Balance Sheet

Natco Pharma Ltd balance sheet discloses shareholders' funds of ₹35.8Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹35.8Cr, and the reserves and surplus of the company is ₹7298.1Cr.

The company has its non-current liabilities with total liabilities of ₹8228.9Cr as of 2025-03-31.

The current liabilities are ₹864.6Cr as of 2025-03-31. At the same time, current assets are ₹4688Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹565.1Cr and tangible assets of ₹2516.8Cr, provided in the Natco Pharma Ltd financial statements.